Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression

被引:35
作者
Seki, T
Hong, KH
Yun, JY
Kim, SJ
Oh, SP
机构
[1] Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL 32610 USA
[2] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA
关键词
activin receptor-like kinase 1; artery-specific gene expression; angiogenesis; hereditary hemorrhagic telangiectasia; transforming growth factor-beta;
D O I
10.1161/01.RES.0000127048.81744.31
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Activin receptor-like kinase 1 (Acvrl1; Alk1) is a type I receptor for transforming growth factor-beta (TGF-beta). ALK1 plays a pivotal role in vascular development and is involved in the development of hereditary hemorrhagic telangiectasia 2 (HHT2), a dominantly inherited vascular disorder, and pulmonary hypertension. We have previously shown that Alk1 is expressed predominantly in arterial endothelial cells (ECs). Despite recent discoveries of a number of artery-specific genes, the regulatory elements of these genes have not been characterized. To investigate the cis-acting elements essential for the artery-specific Alk1 expression, we have generated a series of transgenic constructs with various lengths and regions of Alk1 genomic fragments connected to a LacZ reporter gene, and analyzed the reporter gene expression in transgenic mice. We found that a 9.2-kb genomic fragment, which includes 2.7-kb promoter region and the entire intron 2, is sufficient to drive arterial endothelium-specific expression. The defined regulatory region, as well as the transgenic mouse lines, would be invaluable resources in studying the mechanisms underlying angiogenesis, arteriogenesis, and vascular disorders, such as HHT and pulmonary hypertension. The full text of this article is available online at http://circres.ahajournals.org.
引用
收藏
页码:E72 / E82
页数:11
相关论文
共 38 条
[1]
Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2 [J].
Abdalla, SA ;
Pece-Barbara, N ;
Vera, S ;
Tapia, E ;
Paez, E ;
Bernabeu, C ;
Letarte, M .
HUMAN MOLECULAR GENETICS, 2000, 9 (08) :1227-1237
[2]
Identification of a functional NF-κB site in the platelet endothelial cell adhesion molecule-1 promoter [J].
Botella, LM ;
Puig-Kröger, A ;
Almendro, N ;
Sánchez-Elsner, T ;
Muñoz, E ;
Corbí, A ;
Bernabéu, C .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1372-1378
[3]
The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites [J].
Cowan, PJ ;
Tsang, D ;
Pedic, CM ;
Abbott, LR ;
Shinkel, TA ;
d'Apice, AJF ;
Pearse, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11737-11744
[4]
Dube A, 2001, CIRC RES, V88, P237
[5]
Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries [J].
Ekman, N ;
Lymboussaki, A ;
Vastrik, I ;
Sarvas, K ;
Kaipainen, A ;
Alitalo, K .
CIRCULATION, 1997, 96 (06) :1729-1732
[6]
Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells [J].
Gale, NW ;
Baluk, P ;
Pan, L ;
Kwan, M ;
Holash, J ;
DeChiara, TM ;
McDonald, DM ;
Yancopoulos, GD .
DEVELOPMENTAL BIOLOGY, 2001, 230 (02) :151-160
[7]
Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development [J].
Gerety, SS ;
Wang, HU ;
Chen, ZF ;
Anderson, DJ .
MOLECULAR CELL, 1999, 4 (03) :403-414
[8]
Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription [J].
Gory, S ;
Dalmon, J ;
Prandini, MH ;
Kortulewski, T ;
de Launoit, Y ;
Huber, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6750-6755
[9]
The Vascular Endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice [J].
Gory, S ;
Vernet, M ;
Laurent, M ;
Dejana, E ;
Dalmon, J ;
Huber, P .
BLOOD, 1999, 93 (01) :184-192
[10]
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors [J].
Goumans, MJ ;
Valdimarsdottir, G ;
Itoh, S ;
Rosendahl, A ;
Sideras, P ;
ten Dijke, P .
EMBO JOURNAL, 2002, 21 (07) :1743-1753